SI9620077A - Postopek za pripravo N-monosubstituiranih in N,N'-disubstituiranih nesimetričnih cikličnih sečnin - Google Patents

Postopek za pripravo N-monosubstituiranih in N,N'-disubstituiranih nesimetričnih cikličnih sečnin Download PDF

Info

Publication number
SI9620077A
SI9620077A SI9620077A SI9620077A SI9620077A SI 9620077 A SI9620077 A SI 9620077A SI 9620077 A SI9620077 A SI 9620077A SI 9620077 A SI9620077 A SI 9620077A SI 9620077 A SI9620077 A SI 9620077A
Authority
SI
Slovenia
Prior art keywords
substituted
alkyl
benzyl
group
independently selected
Prior art date
Application number
SI9620077A
Other languages
English (en)
Slovenian (sl)
Inventor
James David Rodgers
Jung-Hui Sun
Original Assignee
Dupont Pharmaceuticals Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Pharmaceuticals Company filed Critical Dupont Pharmaceuticals Company
Publication of SI9620077A publication Critical patent/SI9620077A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SI9620077A 1995-06-07 1996-06-06 Postopek za pripravo N-monosubstituiranih in N,N'-disubstituiranih nesimetričnih cikličnih sečnin SI9620077A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/481,683 US5532357A (en) 1995-06-07 1995-06-07 Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas
PCT/US1996/009021 WO1996040652A1 (en) 1995-06-07 1996-06-06 Method for preparing n-monosubstituted and n,n'-disubstituted unsymmetrical cyclic ureas

Publications (1)

Publication Number Publication Date
SI9620077A true SI9620077A (sl) 1998-08-31

Family

ID=23912954

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9620077A SI9620077A (sl) 1995-06-07 1996-06-06 Postopek za pripravo N-monosubstituiranih in N,N'-disubstituiranih nesimetričnih cikličnih sečnin

Country Status (26)

Country Link
US (1) US5532357A (pt)
EP (2) EP1029859A1 (pt)
JP (1) JPH11506779A (pt)
KR (1) KR19990022467A (pt)
CN (1) CN1192209A (pt)
AR (1) AR002384A1 (pt)
AU (1) AU704535B2 (pt)
BR (1) BR9609493A (pt)
CA (1) CA2223391A1 (pt)
CZ (1) CZ381997A3 (pt)
EA (1) EA000363B1 (pt)
EE (1) EE9700330A (pt)
HR (1) HRP960259A2 (pt)
HU (1) HUP9900913A2 (pt)
IL (1) IL122424A0 (pt)
LT (1) LT4381B (pt)
LV (1) LV12045B (pt)
MX (1) MX9709652A (pt)
NO (1) NO975679L (pt)
NZ (1) NZ309648A (pt)
PL (1) PL323993A1 (pt)
SI (1) SI9620077A (pt)
SK (1) SK164397A3 (pt)
TW (1) TW358091B (pt)
WO (1) WO1996040652A1 (pt)
ZA (1) ZA964847B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466797A (en) * 1994-06-30 1995-11-14 The Du Pont Merck Pharmaceutical Company Intermediates for the preparation of cyclic urea
US6054597A (en) * 1995-11-14 2000-04-25 Dupont Pharmaceuticals Processes and intermediates for the preparation of cyclic urea HIV protease inhibitors
US6218386B1 (en) 1996-11-08 2001-04-17 Dupont Pharmaceuticals A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor
IL129727A0 (en) * 1996-11-08 2000-02-29 Du Pont Pharm Co 1-(3-Aminoindazol-5-YL)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
US5932570A (en) * 1996-11-08 1999-08-03 Dupont Pharmaceuticals Company 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
EP0973767A1 (en) * 1997-03-31 2000-01-26 Dupont Pharmaceuticals Company Indazoles of cyclic ureas useful as hiv protease inhibitors
US6218534B1 (en) 1997-10-06 2001-04-17 Dupont Pharmaceuticals Company Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
WO2000000479A1 (en) * 1998-06-30 2000-01-06 Du Pont Pharmaceuticals Company 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
EP1183242A2 (en) 1999-05-26 2002-03-06 Du Pont Pharmaceuticals Company 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
US6313110B1 (en) * 1999-06-02 2001-11-06 Dupont Pharmaceuticals Company Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor
FR2810039B1 (fr) * 2000-06-13 2007-05-25 Centre Nat Rech Scient Composes urees cycliques et leur procede de preparation
US7015214B2 (en) * 2001-03-28 2006-03-21 Bristol-Myers Squibb Pharma Company Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazepine as HIV reverse transcriptase inhibitors
US7777030B2 (en) * 2005-12-29 2010-08-17 Centre National de la Recherge Scientifique (CNRS) Compositions and methods for the treatment and prevention of disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100268694B1 (ko) * 1991-10-11 2000-10-16 미리암 디. 메코너헤이, 블레어큐. 퍼거슨 레트로바이러스 프로테아제 억제제로 유용한 시클릭 우레아 및 유사체
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5430043A (en) * 1993-08-24 1995-07-04 G. D. Searle & Co. Platelet aggregation inhibitors
US5466797A (en) * 1994-06-30 1995-11-14 The Du Pont Merck Pharmaceutical Company Intermediates for the preparation of cyclic urea
US5530124A (en) * 1994-06-30 1996-06-25 The Dupont Merck Pharmaceutical Company Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors
US5532356A (en) * 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US7344671B2 (en) 2003-11-26 2008-03-18 Glopak Inc. Optical sealing clamp and a method for sealing and cutting polymeric sheets with a laser
US7369013B2 (en) 2005-04-06 2008-05-06 Avago Technologies Wireless Ip Pte Ltd Acoustic resonator performance enhancement using filled recessed region

Also Published As

Publication number Publication date
EP0837855A4 (en) 1998-09-02
WO1996040652A1 (en) 1996-12-19
KR19990022467A (ko) 1999-03-25
CZ381997A3 (cs) 1999-01-13
CA2223391A1 (en) 1996-12-19
US5532357A (en) 1996-07-02
AU704535B2 (en) 1999-04-29
ZA964847B (en) 1997-12-08
NO975679L (no) 1998-02-02
AR002384A1 (es) 1998-03-11
PL323993A1 (en) 1998-04-27
NZ309648A (en) 1998-09-24
LV12045B (en) 1998-09-20
CN1192209A (zh) 1998-09-02
EA199800034A1 (ru) 1998-08-27
MX9709652A (es) 1998-03-29
BR9609493A (pt) 1999-03-02
IL122424A0 (en) 1998-06-15
LT97188A (en) 1998-04-27
TW358091B (en) 1999-05-11
JPH11506779A (ja) 1999-06-15
EP0837855A1 (en) 1998-04-29
LV12045A (lv) 1998-05-20
EA000363B1 (ru) 1999-06-24
LT4381B (lt) 1998-09-25
AU5986896A (en) 1996-12-30
EE9700330A (et) 1998-06-15
NO975679D0 (no) 1997-12-05
HUP9900913A2 (hu) 1999-09-28
HRP960259A2 (en) 1997-10-31
EP1029859A1 (en) 2000-08-23
SK164397A3 (en) 2000-04-10

Similar Documents

Publication Publication Date Title
US5506355A (en) Method for preparing cyclic sulfamides and their use for the synthesis of HIV protease inhibitors
SI9620077A (sl) Postopek za pripravo N-monosubstituiranih in N,N'-disubstituiranih nesimetričnih cikličnih sečnin
EP1656353B1 (en) Gabanergic modulators
EP0923581B1 (en) 4-substituted beta-carbolines as immunomodulators
JP2019528301A (ja) インドールアミン２，３−ジオキシゲナーゼの阻害剤およびその使用方法
CA2462112A1 (en) Spiro-hydantoin compounds useful as anti-inflammatory agents
CA2877826C (en) Tetrahydroquinazolinone derivatives as parp inhibitors
EP0830349B1 (en) Method for preparing n, n'-disubstitued cyclic ureas
ES2241752T3 (es) Derivados de azabicicloalcanos para usar como inhibidores de la recaptacion de serotonina y antagonistas de 5ht2a.
CA3055805A1 (en) N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as ccr6 inhibitors
CA3030697C (en) Pyrazolylaminobenzimidazole derivatives as jak inhibitors
TWI768781B (zh) 轉化生長因子－β受體抑制劑
US5508400A (en) Preparation of cyclic urea compounds
CS268189B2 (en) Method of quinazolinediones and pyridopyrimidinodiones production
JPH10509131A (ja) 新規キノキサリンおよび該キノキサリンからなる医薬品
JP4644655B2 (ja) Ｌｆａ阻害剤として有用なジアゼパン誘導体
TW202412770A (zh) 用於治療ｔｒｐｍ３介導之病症的吲口巾衍生物
Tucker Studies toward the Synthesis of Analogues of the Marine Neurotoxins, Tetrodotoxin and Saxitoxin